Dr. Reddy's Laboratories (RDY) Earnings Date, Estimates & Call Transcripts $13.95 -0.27 (-1.90%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$13.94 -0.01 (-0.11%) As of 08/1/2025 05:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Dr. Reddy's Laboratories Earnings Summary Dr. Reddy's Laboratories released Q1 25/26 earnings on July 23, 2025, reporting an EPS of $0.20, which topped analysts' consensus estimates of $0.18 by $0.02. Quarterly revenue was reported to be $988.82 million, below analyst estimates of $88.27 billion. With a trailing EPS of $0.66 and a P/E Ratio of 21.14, Dr. Reddy's Laboratories' earnings are expected to grow 2.50% next year, from $0.80 to $0.82 per share. Latest Q1 25/26 Earnings DateJul. 23EstimatedConsensus EPS (Jul. 23) $0.18 Actual EPS (Jul. 23) $0.20 Beat By $0.02 Actual Revenue (Jul. 23) $988.82MQ1 25/26 Earnings ResourcesQ1 25/26 Earnings ReportConference Call Transcript & Audio Interim Report Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Dr. Reddy's Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dr. Reddy's Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRDY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RDY Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Dr. Reddy's Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251$1.10$1.10$1.10Q2 20251$0.99$0.99$0.99Q3 20251$1.00$1.00$1.00Q4 20251$0.23$0.23$0.23 FY 2025 4 $3.32 $3.32 $3.32 Q1 20261$0.19$0.19$0.19Q2 20261$0.21$0.21$0.21Q3 20261$0.19$0.19$0.19Q4 20261$0.20$0.20$0.20 FY 2026 4 $0.79 $0.79 $0.79 Q1 20271$0.17$0.17$0.17Q2 20271$0.15$0.15$0.15Q3 20271$0.13$0.13$0.13Q4 20271$0.12$0.12$0.12 Dr. Reddy's Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails7/23/2025Q1 25/26$0.18$0.20+$0.02$0.20$88.27B$988.82M5/9/2025Q4 24/25$0.20$0.22+$0.02$0.22$83.70B$996.17M1/23/2025Q3 24/25$0.19$0.20+$0.01$0.20$975.71M-7/27/2024Q1 24/25$0.22$0.20 -$0.02$1.00$861.68M$919.80M5/7/2024Q4 23/24$0.1720$0.1880+$0.0160$0.94$825.20M$850.00M1/31/2024Q3 23/24$0.1760$0.1980+$0.0220$0.99$827.81M$867.00M10/27/2023Q2 23/24$0.1760$0.2140+$0.0380$1.07$825.94M$832.16M Dr. Reddy's Laboratories Earnings - Frequently Asked Questions When did Dr. Reddy's Laboratories announce their last quarterly earnings? Dr. Reddy's Laboratories (NYSE:RDY) last announced its quarterly earning data on Wednesday, July 23, 2025. Learn more on RDY's earnings history. Did Dr. Reddy's Laboratories beat their earnings estimates last quarter? In the previous quarter, Dr. Reddy's Laboratories (NYSE:RDY) reported $0.20 earnings per share (EPS) to beat the analysts' consensus estimate of $0.18 by $0.02. Learn more on analysts' earnings estimate vs. RDY's actual earnings. How can I listen to Dr. Reddy's Laboratories' earnings conference call? The conference call for Dr. Reddy's Laboratories' latest earnings report can be listened to online. Listen to Conference Call How can I read Dr. Reddy's Laboratories' conference call transcript? The conference call transcript for Dr. Reddy's Laboratories' latest earnings report can be read online. Read Transcript How much revenue does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded annual revenue of $3.81 billion. How much profit does Dr. Reddy's Laboratories generate each year? Dr. Reddy's Laboratories (NYSE:RDY) has a recorded net income of $663 million. RDY has generated $0.66 earnings per share over the last four quarters. What is Dr. Reddy's Laboratories' price-to-earnings ratio? Dr. Reddy's Laboratories (NYSE:RDY) has a trailing price-to-earnings ratio of 21.14 and a forward price-to-earnings ratio of 17.44. The price/earnings-to-growth ratio is 5.57. What is Dr. Reddy's Laboratories' EPS forecast for next year? Dr. Reddy's Laboratories' earnings are expected to grow from $0.80 per share to $0.82 per share in the next year, which is a 2.50% increase. More Earnings Resources from MarketBeat Related Companies Takeda Pharmaceutical Earnings Date argenex Earnings Date BeOne Medicines Earnings Date BioNTech Earnings Date Summit Therapeutics Earnings Date Insmed Earnings Date Teva Pharmaceutical Industries Earnings Date Genmab A/S Earnings Date Moderna Earnings Date QIAGEN Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NYSE:RDY) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredEx-Hedge Fund Manager Uncovers $100 Trillion Land ShiftTrump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to u...Stansberry Research | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredInvestigating the Most Controversial Stock on EarthTesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a st...Brownstone Research | SponsoredThis New Rule Could Change EverythingA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredSell these "safe" blue chips immediatelyInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDY Stock Alerts